Some patients using GLP-1 receptor agonists (including Mounjaro and Wegovy) report increased hair shedding during treatment. Current clinical evidence indicates the medication itself is not usually the direct cause. Hair loss is more commonly associated with rapid weight loss, reduced calorie intake, and nutritional changes that occur alongside treatment.
Why does hair loss happen during weight loss?
Hair follicles are highly sensitive to metabolic stress. Significant or rapid fat loss can trigger telogen effluvium, a temporary condition where a larger proportion of hairs enter the shedding phase of the growth cycle.
Contributing factors may include:
- Rapid calorie restriction
- Low protein intake
- Iron or ferritin deficiency
- Zinc or micronutrient insufficiency
- Hormonal changes
- Physiological stress from weight reduction
This mechanism is well documented in medical weight loss and bariatric literature, including research published in journals such as Annals of Dermatology.
Is hair loss permanent?
No — in the vast majority of cases hair loss linked to weight loss is temporary and reversible.
Hair regrowth typically begins once:
- Weight loss stabilises
- Nutritional intake improves
- The body adapts metabolically
Early regrowth often starts within 3–6 months, with fuller density returning over 6–12 months depending on individual hair cycles.
Which GLP-1 medications are associated with hair shedding?
Hair shedding has been reported anecdotally across the GLP-1 class, including:
- Wegovy & Ozempic (Semaglutide)
- Mounjaro (Tirzepatide)
- Trulicity (Dulaglutide)
- Saxenda (Liraglutide)
Current evidence suggests shedding relates more to the speed and magnitude of weight loss rather than any specific medication.
Who is most at risk of hair loss?
You may be at higher risk if you:
- Lose weight quickly (1.5 kg per week)
- Consume inadequate protein
- Have low iron stores or anaemia
- Have thyroid dysfunction
- Are peri-menopausal or post-partum
- Have a prior history of telogen effluvium
How can hair loss be minimised during GLP-1 treatment?
Preventative strategies focus on nutritional optimisation and safe weight loss pacing:
- Protein intake: Aim for 1.0–1.5 g per kg body weight daily
- Iron optimisation: Maintain healthy ferritin levels through eating iron containing foods or taking an iron supplement
- Micronutrients: Ensure adequate zinc, biotin, vitamin D, B12, and folate
- Gradual weight loss: Avoid excessively rapid calorie restriction
- Hydration and calorie adequacy
Dietary guidance on micronutrient sufficiency is supported by the British Dietetic Association.
Should I stop my GLP-1 medication if I notice hair loss?
Stopping treatment is rarely necessary. Doing so may interrupt your treatment progress. You could however try stopping your treatment for a few weeks to see if your hair loss improves.
Furthermore, f you have tried some of the self help measure above and things are not improving then it would be worth booking a blood test with your GP to test for other underlying causes such as:
- Iron studies
- Thyroid function
- Vitamin B12
- Folate
- Vitamin D
Are supplements helpful?
Supplements may support hair regrowth where deficiencies exist, but they should complement — not replace — dietary intake.
Evidence-based options may include:
- Iron (if deficient)
- Zinc
- Biotin (if intake is low)
- Protein or collagen supplementation
When should I seek medical advice?
Seek review with your NHS GP if you experience:
- Shedding lasting longer than 3 months
- Patchy or focal hair loss
- Scalp inflammation or itching
- Fatigue or anaemia symptoms
- Hormonal or thyroid irregularities
Further clinical guidance is available via the NHS website.
Hair loss during GLP-1 treatment is typically temporary, nutritionally mediated, and reversible. With appropriate monitoring, dietary optimisation, and clinically supervised weight loss, most patients maintain healthy hair regrowth throughout their treatment journey.